Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07179952
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
A Study to Evaluate Efficacy and Safety of Slow Release DHEA
Sponsor: Indiana University
Conditions
Asthma
Interventions
Placebo Slow Release DHEA
Updated 3 times since 2025 Last updated: Feb 25, 2026 Started: Jan 1, 2027 Primary completion: Sep 30, 2028 Completion: Sep 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Asthma, this trial is actively recruiting participants. The trial is conducted by Indiana University and has accumulated 3 data snapshots since 2027. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Feb 2026 — Present [monthly]
Not Yet Recruiting PHASE2
-
Dec 2025 — Feb 2026 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2025 — Dec 2025 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Indiana University
- National Heart, Lung, and Blood Institute (NHLBI)
Data source: Indiana University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.